The College of American Pathologists (CAP), hosted on Tuesday, Sept 1, The Rapidly Changing COVID-19 Testing Landscape: Where We Are/Where We Are Going, the first in a series of virtual media briefings.
The College of American Pathologists (CAP) issued the following statement asking the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) to provide the scientific rationale when changing COVID-19 testing guidance.
The proposed 2021 Medicare Physician Fee Schedule (PFS) issued by the Centers for Medicare & Medicaid Services (CMS) on August 3, 2020 failed to address a significant shift in physician and nonphysician payments.
Reports of increasing numbers of pregnant women with COVID-19 show that most neonates (newborn infants) are uninfected by the new coronavirus, SARS-CoV-2. However, a very small number of neonates have tested positive for COVID-19.
For the fifth year, the College of American Pathologists (CAP) has been named to Center for Companies That Care’s Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement.
The CAP highlighted the undercount of US pathologists in an article published by the Journal of the American Medical Association (JAMA) Network Open and further called for previous works citing the data to be corrected.
With over 25 years of marketing, sales and general management experience in the medical device industry, Mary de Sousa brings to the College of American Pathologists (CAP) a deep understanding of the rapidly changing health care landscape from a financial and commercial standpoint.